Latest News


Vertical / Trigen Holdings, LLC and Osmotica Holdings Corp Successfully Complete Combination
February 4, 2016

SAYREVILLE, N.J. and MARIETTA, Ga., February 4, 2016 /PRNewswire/ — Vertical / Trigen Holdings, LLC (“Vertical / Trigen”) and Osmotica Holdings Corp Limited (“Osmotica”) today announced the successful completion of their previously announced combination, creating a world-class, fully-integrated specialty pharmaceutical and generics company. The combined company, which will retain the Osmotica name, is jointly owned… Full Article

Vertical / Trigen Holdings, LLC and Osmotica Holdings Corp Limited to Combine, Creating World-Class, Fully-Integrated Specialty Pharmaceuticals Company
December 4, 2015

SAYREVILLE, N.J. and MARIETTA, Ga., Dec. 4, 2015 /PRNewswire/ — Vertical / Trigen Holdings, LLC (“Vertical / Trigen”) and Osmotica Holdings Corp Limited (“Osmotica”) today announced that they have entered into a definitive agreement to combine, creating a world-class, fully-integrated specialty pharmaceutical and generics company. Vertical / Trigen is a portfolio company of Avista Capital Partners… Full Article

MONISTAT® and Vertical Pharmaceuticals Team Up to Help Healthcare Professionals Treat Yeast Infections
September 16, 2015

TARRYTOWN, NY – September 16, 2015 – Prestige Brands Holdings, Inc., the makers of MONISTAT®, and Vertical Pharmaceuticals, LLC are partnering in an effort to help patients and healthcare practitioners better treat yeast infections. MONISTAT®, the #1 doctor-recommended over-the-counter vaginal yeast infection treatment, has teamed up with Vertical Pharmaceuticals to detail OBGYN offices and clinics… Full Article

Vertical Pharmaceuticals, LLC Acquires Portfolio of Branded Women’s Health Products from Upsher-Smith Laboratories, Inc.
March 24, 2014

Avista Capital Partners-Backed Company to Continue Add-On Acquisition Strategy Sayreville, NJ, March 24, 2014 – Vertical Pharmaceuticals, LLC, a wholly owned subsidiary of Vertical / Trigen Holdings, LLC (“Vertical / Trigen”), today announced that it has acquired the rights to three branded women’s health products from Upsher-Smith Laboratories, Inc. The terms of the transaction were… Full Article

Avista Capital Partners Announces a Majority Investment in Vertical Pharmaceuticals and Trigen Laboratories
December 30, 2013

New York, NY, and Sayreville, NJ, December 16, 2013 – Avista Capital Partners (“Avista”), a leading private equity firm, and Vertical / Trigen Holdings (“Vertical / Trigen” or “the Company”), which owns Vertical Pharmaceuticals and Trigen Laboratories, today announced that Avista has acquired a controlling equity interest in Vertical / Trigen. Avista is partnering with… Full Article